EICHORCondition: Glaucoma · Ocular Hypertension · Sponsor: Laboratoires Thea
The main study purpose is to demonstrate the non-inferiority of T4032 compared to Lumigan® 0.01% in terms of efficacy.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Informed consent dated and signed. * Both eyes diagnosed open-angle glaucoma or ocular hypertension Exclusion Criteria: * History of trauma, infection, clinically significant inflammation within the previous 3 months * Known or suspected hypersensitivity to one of the components of the Investigational Medicinal Product(s) * Pregnancy or breast-feeding
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Arizona Eye Center - Chandler | Chandler, Arizona, United States | — |
| Eye Physicians & Surgeons of Arizona - Glendale Office | Glendale, Arizona, United States | — |
| Arizona Glaucoma Specialists - Phoenix | Phoenix, Arizona, United States | — |
| Walman Eye Center - Sun City | Sun City, Arizona, United States | — |
| Velvet Clinical Research | Burbank, California, United States | — |
| Specialty Eye Care Medical Center - Glendale | Glendale, California, United States | — |
| Global Research Management, Inc. | Glendale, California, United States | — |
| Inland Eye Specialists - Hemet | Hemet, California, United States | — |
| Diabetic Eye Medical Clinic - Inglewood | Inglewood, California, United States | — |
| Lakeside Vision Center - Irvine | Irvine, California, United States | — |
| Sage Eyecare | Los Angeles, California, United States | — |
| Global Vision Eye Care - Los Angeles- Rock Central | Los Angeles, California, United States | — |
+ 52 more locations — full list on the registry record.
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05397600